logo
logo

Bionter Ag Secures $3 Million In Series Seed Financing Led By Dynamk Capital

Apr 27, 2022•about 3 years ago

Amount Raised

$3 Million

Round Type

seed

Riehen

Description

Bionter AG, experts in sub-visible particle testing, announced the completion of a $3 million Series Seed financing from Dynamk Capital. Bionter revolutionizes analytical testing of subvisible particles in the biopharmaceutical industry in respect to economy, process time and safety.

Company Information

Company

Bionter Ag

Location

Riehen, Basel-Stadt, Switzerland

About

Bionter (www.bionter.com) is a recently founded Switzerland based company with the purpose of revolutionizing analytical testing for the benefit of people's health. Bionter is driving patient safety, cost efficiency and sustainability through disruptive innovations in particle testing that are increasing the quality of drug product testing. Bionter`s first product is a particle counter that is not only fully automated but also allows non-destructive sample testing.